论文部分内容阅读
目的:评价间苯三酚与哌替啶联用对初产孕妇分娩过程中产后出血量与新生儿的影响。方法:选取2013年3月—2014年8月医院收治的初产孕妇120例;将其分为观察组和对照组,每组60例;在其分娩过程中观察组患者给予间苯三酚注射液与哌替啶注射液联用,对照组患者给予常规处理治疗,比较两组患者治疗后产程时间、不良反应的发生率及对新生儿影响的评分值。结果:观察组患者总产程平均时间、剖宫产率和不良反应的发生率分别为(285.9±71.4)min、6.67%和1.67%显著低于对照组为(418.9±78.7)min、13.33%和41.67%(P<0.05),前者产后出血量为(158.5±24.2)m L与对照组为(152.8±33.4)m L,经比较其差异无统计学意义(P>0.05);观察组患者新生儿评分值为(9.75±1.14)分明显高于对照组为(7.85±0.95)分(P<0.05)。结论:在初产妇分娩过程中给予间苯三酚注射液与哌替啶注射液联用治疗优于常规处理治疗,缩短了分娩产程且安全可靠,对新生儿无影响。
Objective: To evaluate the effect of phloroglucinol combined with pethidine on the amount of postpartum hemorrhage and neonatal during delivery in primiparous pregnant women. Methods: A total of 120 primiparous women were enrolled in the hospital from March 2013 to August 2014. They were divided into observation group and control group, with 60 cases in each group. The patients in the observation group were given phloroglucinol Liquid combined with injection of pethidine, the control group of patients given conventional treatment of treatment, the two groups of patients after treatment of labor time, the incidence of adverse reactions and neonatal impact score. Results: The average length of labor, cesarean section rate and adverse reaction rate in the observation group were (285.9 ± 71.4) min, 6.67% and 1.67%, respectively, which were significantly lower than those in the control group (418.9 ± 78.7) min and 13.33% (P <0.05). The former was (158.5 ± 24.2) m L and the control group was (152.8 ± 33.4) m L, but the difference was not statistically significant Children score was (9.75 ± 1.14) points higher than the control group (7.85 ± 0.95) points (P <0.05). Conclusion: The combination of phloroglucinol injection and pethidine injection in primipara during delivery is superior to routine treatment, shorten the delivery process and safe, reliable and has no effect on neonates.